Daniel Lietha was born in 1970 in Chur (Switzerland). He received his undergraduate degrees in Chemistry in 1995 from the Zürcher Hochschule für Angewandte Wissenschaften (Switzerland) and in Biotechnology in 1998 from Teesside University (UK).
In 2003 he obtained his PhD degree in Protein Crystallography from Birkbeck College (UK). For his postdoctoral training he joined the laboratory of M.J. Eck at the Dana-Faber Cancer Institute, Harvard Medical School, Boston (USA) where he worked on the molecular mechanisms involved in cell-matrix adhesion.
In September 2009 Daniel joined the CNIO as Junior Group Leader in the Structural Biology and Biocomputing Programme. His research focuses on molecular mechanisms of cell signalling and adhesion, downstream of growth factor receptor and integrin signalling.
Daniel received a predoctoral award from the Roche Research Foundation and a postdoctoral fellowship from the National Cancer Institute (NCI), Bethesda (USA). He has authored several high-profile peerreviewed articles and his graduate work has led to a patent on MET agonists for the use in tissue and organ regeneration.
As of 2011 he will be granted a research contract from the Ramón y Cajal Programme (funded by the Ministerio de Ciencia e Innovación).